Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Envision TD fluocinolone acetonide: Phase III data

In a Phase III trial in 80 patients, treatment with 0.5 mg of Envision TD improved diabetic

Read the full 176 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE